phenethyl isothiocyanate has been researched along with Experimental Mammary Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gartel, AL; Halasi, M; Hay, N; Nogueira, V; Pandit, B; Wang, M | 1 |
| Adkins, C; Gupta, P; Lockman, P; Srivastava, SK | 1 |
| Badve, S; McCune, K; Mehta, R; Nakshatri, H; Thorat, MA | 1 |
| Arlotti, JA; Beumer, JH; Chandra-Kuntal, K; Dhir, R; Hahm, ER; Jankowitz, RC; Kim, SH; Lee, J; Powolny, AA; Sakao, K; Sehrawat, A; Singh, SV | 1 |
| Eto, I; Grubbs, CJ; Juliana, MM; Kelloff, GJ; Lubet, RA; Steele, VE | 1 |
| Futakuchi, M; Hirose, M; Miki, T; Ozaki, M; Shirai, T; Tanaka, H | 1 |
6 other study(ies) available for phenethyl isothiocyanate and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Combination of oxidative stress and FOXM1 inhibitors induces apoptosis in cancer cells and inhibits xenograft tumor growth.
Topics: 2-Methoxyestradiol; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Boronic Acids; Bortezomib; Cell Line, Tumor; Drug Administration Schedule; Estradiol; Female; Forkhead Box Protein M1; Forkhead Transcription Factors; Humans; Isothiocyanates; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Oxidative Stress; Pyrazines; Random Allocation; Reactive Oxygen Species; RNA Interference; Transplantation, Heterologous; Treatment Outcome | 2013 |
Metastasis of Breast Tumor Cells to Brain Is Suppressed by Phenethyl Isothiocyanate in a Novel In Vivo Metastasis Model.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Cell Line, Tumor; Female; Heart Ventricles; Isothiocyanates; Kaplan-Meier Estimate; Luciferases; Mammary Neoplasms, Experimental; Mice, Nude; Neoplasm Metastasis; Quantum Dots; Transfection; Xenograft Model Antitumor Assays | 2013 |
Loss of ERĪ± and FOXA1 expression in a progression model of luminal type breast cancer: insights from PyMT transgenic mouse model.
Topics: Animals; Anticarcinogenic Agents; Cell Growth Processes; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Estrogen Receptor alpha; Female; GATA3 Transcription Factor; Gene Expression Regulation, Neoplastic; Hepatocyte Nuclear Factor 3-alpha; Isothiocyanates; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Neoplastic Stem Cells; Prognosis | 2010 |
Biomarkers of phenethyl isothiocyanate-mediated mammary cancer chemoprevention in a clinically relevant mouse model.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Female; Gene Expression Profiling; Immunohistochemistry; In Situ Nick-End Labeling; Isothiocyanates; Ki-67 Antigen; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mass Spectrometry; Mice; Mice, Transgenic; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Prealbumin | 2012 |
Chemopreventive efficacy of anethole trithione, N-acetyl-L-cysteine, miconazole and phenethylisothiocyanate in the DMBA-induced rat mammary cancer model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Acetylcysteine; Anethole Trithione; Animals; Anticarcinogenic Agents; Body Weight; Female; Isothiocyanates; Mammary Neoplasms, Experimental; Miconazole; Rats; Rats, Sprague-Dawley; Time Factors | 1997 |
Inhibition of DMBA-initiated rat mammary tumour development by 1-O-hexyl-2,3,5-trimethylhydroquinone, phenylethyl isothiocyanate, and novel synthetic ascorbic acid derivatives.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Anticarcinogenic Agents; Antioxidants; Ascorbic Acid; Carcinogens; Cell Transformation, Neoplastic; Chemoprevention; Diet; Female; Hydroquinones; Isothiocyanates; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley | 1998 |